Crowdonomics
All companies
Pops logo

Pops

Operating

POPS! Diabetes Care, Inc.

Healthcare · Technology · Minneapolis, MN · Founded 2015

Self-care AI med-tech platform and glucometer that enables people to manage their own diabetes.

Post-money valuation ⓘ
$17.9M
As of Jul 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$16,012,770
Crowd $475K · Private $15.5M · 7 rounds since 2016
Latest share price
$7.43
Reg CF · Series A-2 Preferred Stock · Apr 2022 offering price

Financials

FY2019–FY2021 · from SEC filings · hover any figure for its source
$6K
−$1.9M
2019
$29K
−$1.7M
2020
$163K
−$2.4M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed*
FY2021
Income statement
Revenue
$5,994
$28,684
$163,164
Cost of goods sold
$12,105
$23,856
$446,239
Gross margin
-102%
17%
-173%
Net income
-$1,852,905
-$1,651,287
-$2,427,152
Taxes paid
$0
$0
$0
Balance sheet
Cash
$1,284,047
$1,426,581
$249,701
Accounts receivable
$0
$2,627
$28,080
Total assets
$2,167,607
$2,068,597
$1,166,946
Short-term debt
$424,040
$446,691
$792,560
Long-term debt
$188,400
$1,703,070
$2,880,394
Total liabilities
$612,440
$2,149,761
$3,672,954
Other
Headcount
—
8
8

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$25.0M
Valuation cap
$17.9M
pre-money
Reg CF · Series A-2 Preferred · May 2021
Reg CF · Series A-2 Preferred · Apr 2022

Blue bars are the pre-money valuation the company stated for a priced round. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.

Share price over rounds

$7.43$3.715$7.43
Jun 2019Apr 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines, and each class is drawn as its own line.

Fundraising history

Raised $48.1K / $2.6MInvestors 41Post-money $17.9M
Raised $426.8K / $1.1MInvestors 41Valuation cap $25M
Raised $5.9MInvestors 57
Raised $1.2MInvestors 15
Raised $500KInvestors 28

Team

11 people
Curt ChristensenFounder
VP Manufacturing, Co-Founder, and Director

Curt has never met a manufacturing challenge he could not conquer. As our VP of Manufacturing and one of Pop's founders, Curt has been instrumental in putting quality processes in place for our products and serving our users. Curt has more than 40 years of experience doing manufacturing and quality support at 3M and Pops.

Dan DavisFounder
VP of R&D, Co-Founder and Director

Dan is our champion of product development as our VP of R&D. Dan has led many products from research through commercialization, and he loves creating a Pops experience that people rave about. Prior to co-founding Pops, Dan spent time at 3M, Otto Bock, Nolato, and other companies developing and manufacturing products.

Lonny StormoFounder
Chairman of the Board, Co-Founder and CEO

As one of the Co-Founders of Pops, and as our CEO, Lonny brings his deep passion for user experience and changing lives to enable the total Pops Mission. Lonny has led Pops for six years including successfully generating investment capital. Prior to Pops, Lonny spent 30-years at Medtronic in a variety of roles including executive roles leading a $1B business unit. Lonny left Medtronic to co-found Pops.

Daniel DavisFounder
VP of RandD, Co-Founder, and Director
George Arida
Chief Financial Officer, Chief Operating Officer and Director

George is one of Pop's directors on our board. George helps guide our board, CEO, and company direction with his thoughtful approach. He has a great blend of technical and investing background, including 18 years at Venture Investors before founding 30 Ventures, which invested in Pops.

Timothy Balder MD
Chief Medical Officer

Tim's mission has always been to help people live more healthy lives, and he delivered on that passion as a practicing primary care physician for many years. Now, as Pops' Chief Medical Officer, Tim is helping people live their healthiest life through the Pops platform. Tim's experience includes practicing primary care for more the 30 years.

Janet Stormo
VP Operations

Janet's passion is driving efficiency and creating order. She works as our VP of Operations across all of our departments to improve processes, generate metrics to run the business, and ensure our clients and owners are getting the experience they deserve. Janet brings more than 25 years of experience at Medtronic and Honeywell, including leading Medtronic's US customer service and field inventory teams.

Kevin Lunke
Business Development Manager

Kevin is our leader for client sales. Kevin has great passion for searching out and landing those clients who can benefit the most from working with Pops. He has worked with multiple startups to create and grow their client sales. Kevin has more than eight years of experience in business development and startup investing.

Kim Mageau
Vice Chair of the Board of Directors

Kim brings to our Pops board strong perspective from her many leadership roles in the healthcare payer industry and beyond. Kim's experience helps our board to stay focus on our user and clinical outcomes, as well as doing what is right for our founders and employees. Kim has many years of experience as both leader and director for multiple businesses.

Show 2 more people
Stephanie Toomey
Customer Success Director

As our Customer Success Director, Stephanie ensures that each of our clients and users get a premier experience. She leads all of the marketing, enrollment, and digital presence activities at Pops. Stephanie has more than ten years of experience in this area with most of that at an online and TV shopping company, Shop HQ.

Tom Tefft
Director

Tom brings a broad view as a medical device executive to the Pops board. His background of business leadership and finance has landed him multiple board positions at large established companies and startups. With this experience, Tom helps guide the company, team, and CEO from raising capital to execution to budges and plans.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 5 annual reports (FY2021–FY2025)

57 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-UJul 29, 20220001665160-22-002113
    EDGAR
  • Form C-ARApr 29, 20220001665160-22-001304
    EDGAR
  • Form CApr 27, 20220001665160-22-001025
    EDGAR
  • Form C-UAug 3, 20210001664262-21-000003
    EDGAR
  • Form CMay 24, 20210001664262-21-000001
    EDGAR
  • Form DAug 19, 20190001437749-19-017120
    EDGAR
  • Form DJan 3, 20180001209191-18-000480
    EDGAR
  • Form DJan 13, 20170001209191-17-003726
    EDGAR
Source: ManualCIK 0001664262DEShare price $7.43

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.